Neil Butler, PhD is an Associate in Venture Investments at Kendall Capital Partners. At Kendall, Dr. Butler focuses on identifying and evaluating novel biotechnology and healthcare innovations and investment opportunities in early-stage companies. Dr. Butler brings experience as both a scientist and an entrepreneur to the investment team as a founder of the early-stage vaccine company Nitro Biosciences. 

Dr. Butler holds a PhD from the University of Delaware in Chemical Engineering and a BS from Penn State University. With academic training as a chemical engineer, he brings subject matter expertise in synthetic biology, protein engineering, and immunology to the investment team.